Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death

Photodiagnosis and Photodynamic Therapy

Volumn 9, Issue 2, 2012, Pages 156-163

  Sharma, Krishna V ^a   Davids, Lester M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Hypericin; Kojic acid; Melanoma; Photodynamic therapy; Reactive oxygen species

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; HYPERICIN; KOJIC ACID; MELANIN; MONOPHENOL MONOOXYGENASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CELL VIABILITY; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPIGMENTATION; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MELANOGENESIS; MELANOMA CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT DURATION; ULTRAVIOLET IRRADIATION;

APOPTOSIS; CELL LINE, TUMOR; HUMANS; MELANINS; MELANOMA; PERYLENE; PHOTOCHEMOTHERAPY; PIGMENTATION; RADIATION-SENSITIZING AGENTS;

EID: 84861007349     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2011.09.003     Document Type: Article

References (28)

1. Carlson J.A., Ross J.S., Slominski A., et al. Molecular diagnostics in melanoma. J Am Acad Dermatol 2005, 52:743-775. (quiz 775-8).
2. Moncrieff M.D., Martin R., O'Brien C.J., et al. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?. Ann Surg Oncol 2008, 15:3022-3027.
3. Yamamura H., Ugawa S., Ueda T., Morita A., Shimada S. TRPM8 activation suppresses cellular viability in human melanoma. Am J Physiol Cell Physiol 2008, 295:296-301.
4. Chudnovsky Y., Khavari P.A., Adams A.E. Melanoma genetics and the development of rational therapeutics. J Clin Invest 2005, 115:813-824.
5. Slominski A., Tobin D.J., Shibahara S., Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004, 84:1155-1228.
6. Slominski A., Wortsman J., Carlson A.J., Matsuoka L.Y., Balch C.M., Mihm M.C. Malignant melanoma. Arch Pathol Lab Med 2001, 125:1295-1306.
7. Thompson J.F., Scolyer R.A., Kefford R.F. Cutaneous melanoma. Lancet 2005, 365:687-701.
8. Davids L.M., Kleemann B. Combating melanoma: the use of photodynamic therapy as a novel, adjuvant therapeutic tool. Cancer Treat Rev 2011, 37(6):465-475.
9. Saczko J., Kulbacka J., Chwiłkowska A., et al. The influence of photodynamic therapy on apoptosis in human melanoma cell line. Folia Histochem Cytobiol 2005, 43(3):129-132.
10. Davids L.M., Kleemann B., Cooper S., Kidson S.H. Melanomas display increased cytoprotection to hypericin-mediated cytotoxicity through the induction of autophagy. Cell Biol Int 2009, 33:1065-1072.
11. Hadjur C., Richard M.J., Parat M.O., Jardon P., Favier A. Photodynamic effects of hypericin on lipid peroxidation and antioxidant status in melanoma cells. Photochem Photobiol 1996, 64:375-381.
12. Sealy R.C., Sarna T., Wanner E.J., Reszka K. Photosensitization of melanin: an electron spin resonance study of sensitized radical production and oxygen consumption. Photochem Photobiol 1984, 40:453-459.
13. Sarna T., Menon I.A., Sealy R.C. Photosensitization of melanin: a comparative study. Photochem Photobiol 1985, 42:529-532.
14. Sarna T., Pilas B., Land E.J., Truscott T.G. Interaction of radicals from water radiolysis with melanin. Biochem Biophys Acta 1986, 883:162-167.
15. Korytowski W., Kalyanaraman B., Menon I.A., Sarna T., Sealy R.C. Reaction of superoxide anions with melanins: electron spin resonance and spin trapping studies. Biochem Biophys Acta 1986, 882:145-153.
16. Brozyna A.A., VanMiddlesworth L., Slominski A.T. Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy. Int J Cancer 2008, 123:1448-1456.
17. Slominski A., Zbytek B., Slominski R. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer 2009, 124:1470-1477.
18. Battaini G., Monzani E., Casella L., Santagostini L., Pagliarin R. Inhibition of the catecholase activity of biomimetic dinuclear copper complexes by kojic acid. J Biol Inorg Chem 2000, 5:262-268.
19. Burdock G.A., Soni M.G., Carabin I.G. Evaluation of health aspects of kojic acid in food. Regul Toxicol Pharmacol 2001, 33:80-101.
20. Masse M.O., Duvallet V., Borremans M., Goeyens L., Identification quantitative analysis of kojic acid and arbutine in skinwhitening cosmetics. Int J Cosmet Sci 2001, 23:219-232.
21. Ohyama Y. Melanogenesis-inhibitory effect of kojic acid and its action mechanism. Frag J 1990, 6:53-58.
22. Kwak M.Y., Rhee J.S. Cultivation characteristics of immobilized Aspergillus oryzae for kojic acid production. Biotechnol Bioeng 1992, 39:903-906.
23. Siegrist W., Eberle A.N. In situ melanin assay for MSH using mouse B16 melanoma cells in culture. Anal Biochem 1986, 159:191-197.
24. Virador V.M., Kobayashi N., Matsunaga J., Hearing V.J. A standardized protocol for assessing regulators of pigmentation. Anal Biochem 1999, 270:207-219.
25. Mousavi S.H., Tavakkol-Afshari J., Brook A., Jafari-Anarkooli I. Direct toxicity of Rose Bengal in MCF-7 cell line: role of apoptosis. Food Chem Toxicol 2009, 47:855-859.
26. Sharma K.V., Sisodia R. Evaluation of the free radical scavenging activity and radioprotective efficacy of Grewia asiatica fruit. J Radiol Prot 2009, 29:429-443.
27. Wood J.M., Jimbow K., Boissy R.E., et al. What's the use of generating melanin?. Exp Dermatolo 1999, 8(2):153-164.
28. Mroz P., Huang Y.Y., Szokalska A., et al. Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy. FASEB J 2010, 24:3160-3170.